IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
The UK have some of the lowest global survival rates for lung cancer.
Early diagnosis is critical for patients to be able to access AstraZeneca’s life-saving, innovative products and improve outcomes, but NHS workers do not have capacity to address this challenge on a systematic scale.
Regional heterogeneity in care is impacting efficacy of lung cancer services. Impactful change requires engagement from the NHS, which will support initiatives to develop and test new models of care
PATHFINDER was a collaborative initiative between the NHS, AstraZeneca and IQVIA aiming to support the NHS in understanding current patient pathways and implementing changes to facilitate earlier diagnosis of lung cancer.
Re-engineering the National Lung Cancer Best Practice Pathway:
Working with the NHS National Lung Cancer team, IQVIA played a pivotal role in improving lung cancer care pathways, providing a roadmap to help NHS Hospitals deliver treatment faster, reducing patient review times.
Implementing optimised pathway steps identified through pathfinder nationally could release or 2,430 days of capacity if patients were treated within 21 days.
PATHFINDER is providing a roadmap to help trusts deliver treatment faster, helping to reach these targets
Patient review times reduced: 5 days < 24 hours
PET-CT scan wait time reduce: 5-7 days < 2 days
Improved sample collection & delivery: 80% now reach lab on same day
2 findings incorporated into GRIFT facilitating improved MDT working
Future opportunities to disseminate findings across the cancer clinical community, allowing solutions to be leveraged across other centres and other cancer areas
Body text area. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur at orci in eros blandit fermentum eu eget nulla. Vestibulum ornare felis metus. Quisque efficitur lorem ut justo ornare laoreet. Proin blandit dui consectetur malesuada vehicula. Morbi consequat eros dolor, ut tristique ex aliquet ac. Suspendisse posuere pulvinar purus, sed tempor magna eleifend sit amet. Mauris viverra tincidunt ligula, at porta ex mollis eget. Integer nec lacus faucibus nisi bibendum accumsan. Cras tristique est nec est semper volutpat. Interdum et malesuada fames ac ante ipsum primis in faucibus. Mauris neque arcu, blandit vitae velit quis, finibus cursus justo. Etiam eu ante turpis. Nunc ac nisl scelerisque, iaculis justo et, semper quam. Aenean vestibulum condimentum leo.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.